Prevalence of resistance phenotypes in staphylococcus aureus and coagulase-negative isolates of venous ulcers of primary healthcare patients;Prevalência de fenótipos de resistência em staphylococcus aureus e coagulase negativos isolados de úlceras venosas de pessoas atendidas na atenção primária

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 6, 2012, Pages 717-722

  Martins, Marlene Andrade ^a   De Lima Vieira dos Santos, Silvana ^a   De Oliveira Leão, Lara Stefânia Netto ^a   Araújo, Nayara Portilho ^b   Bachion, Maria Márcia ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Centro de Assistência Integral à Saúde CAIS Chácara do Governador   (Brazil)

Author keywords

Drug resistance bacterial; Methicillin resistant staphylococcus aureus; Primary health care; Varicose ulcer

Indexed keywords

BETA LACTAMASE; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COAGULASE; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; LINCOSAMIDES; MACROLIDES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE; PREVALENCE; PRIMARY HEALTH CARE; STAPHYLOCOCCUS AUREUS; STREPTOGRAMIN GROUP B; VARICOSE ULCER;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84872468784     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000600012     Document Type: Article

References (40)

1. nd edition, CRC Press, Taylor & Francis Group. 2010; p. 409.
2. European Wound Management Association (EWMA). Position document: Identifying criteria for wound infection. London Medical Education Partnership, Ltd, 2005. p. 1-19.
3. Hersh A, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168:1585-1591.
4. Gordon RJ, Lowy FD. Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection. Clin Infect Dis 2008; 46 (suppl 5):350-359.
5. Zurita J, Medjía C, Guzmán-Blancos M. Epidemiology and surveillance of methicillin resistant Staphylococcus aureus in Latin America. Braz J Infect Dis 2010; 14 (suppl 2):79-86.
6. Alvarez C, Labarca J, Salles M. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America. Braz J Infect Dis 2010; 14 (suppl 2):107-118.
7. Howell-Jones, RS, Price PE, Howard AJ, Thomas DW. Antibiotic prescribing for chronic skin wounds in primary care. Wound Rep Reg 2006; 14:387-393.
8. Kirketerp-Moller K, Jensen PO, Fazli M, Madsen GK, Pedersen J, Moser C, et al. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 2008; 46:2717-2722.
9. Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G. Inducible clindamycin resistance in Staphylococci isolated from clinical samples. J Infect Dis 2005; 58:104-106.
10. Fokas S, Fokas S, Tsironi M, Kalkami M, Dionysopouloy M. Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect Dis 2005; 11:337-340.
11. Amorim DMR, Person OC, Amaral PJ, Tanaka II. Resistência induzível à clindamicina entre isolados clínicos de Staphylococcus aureus. O Mundo da Saúde 2009; 33:401-405.
12. Gardner SE, Frantz RA, Saltzman CL, Dodgson KJ Staphylococcus aureus is associated with high microbial load in chronic wounds. Wounds 2004; 16:251-257.
13. Miller CN, Carville K, Newall N, Kapp S, Lewin G, Karimi I, Santamaria N. Assessing bacterial burden in wounds: comparing clinical observation and wound swabs. Internat Wound J 2010; 8:45-55.
14. Elaine P, Ferreira E, Marques A, Matos B. Infecções associadas aos cuidados de saúde e segurança do doente. Rev Port Saude Publica 2010; 10:27-39.
15. Levine NS, Lindberg RB, Mason AD, Pruitt Jr BA. The quantitative swab culture and smear: a quick, simple method for determining the number of viable aerobic bacteria on open wound. J Trauma 1976; 16:89-94.
16. Angel DE, LIoyd P, Carville K, Santamaria N. The clinical efficacy of two semi-quantitative wound-swabbing techniques in identifying the causative organism(s) in infected cutaneous wounds. Internat Wound J 2011; 8:176-185.
17. Oplustil CP, Zoccoli CM, Tobouti NR, Sinto SI. Procedimentos básicos em microbiologia clínica. Editora Sarvier: São Paulo; 2010.
18. nd edition, Medsi: Rio de Janeiro; 2008.
19. Rossi F, Andreazzi DB. Resistência bacteriana - interpretando o antibiograma. Editora Atheneu: São Paulo; 2005. p. 118.
20. th edition. M7-A8, M100-S21, Wayne, PA: USA, 2009.
21. nd edition. M2-A8, Wayne, PA: USA, 2003.
22. British Society for Antimicrobial Chemotherapy (BSAC). Methods for Antimicrobial Susceptibility Testing 2009; 8:91.
23. Martins MA, Tipple AFV, Reis C, Santiago SB, Bachion MM. Úlcera crônica de perna de pacientes em tratamento ambulatorial: análise microbiológica e de suscetibilidade antimicrobiana. Cienc Cuid Saude 2010; 9:464-470.
24. Ferreira AW, Vasconcelos WS, Ferreira CM, Silva MFP, Gomes JS, Alecrim MGC. Prevalência de Staphylococcus aureus meticilina resistente (MRSA) em pacientes atendidos em ambulatório de dermatologia geral em Manaus-Amazonas. Rev Patol Trop 2009; 38:83-92.
25. Kobayashi CCBA, Sadoyama G, Vieira JDG. Determinação da resistência antimicrobiana associada em isolados clínicos de Staphylococcus aureus e Pseudomonas aeruginosa em um hospital público de Goiânia, Estado de Goiás. Rev Soc Bras Med Trop 2009; 42:404-410.
26. Kim HB, Jang HC, Nam H, Lee YS, Kim BS, Park WB, et al. In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from Tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 2004; 48:1124-1127.
27. Rossi F, Garcia P, Ronzon B, Curcio D, Dowzick MJ. Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro Activity of the Glycylcycline Tigecycline and of Other Antibiotics. Braz J Infect Dis 2008; 12:405-415.
28. Luna CM, Rodríguez-Noriega E, Bavestrello L, Gotuzzo E. Treatment of methicillin-resistant Staphylococcus aureus in Latin America. Braz J Infec Dis 2010; 14:119-127.
29. Quege GE, Bachion MM, Lino-Junior RSL, Lima ABM, Ferreira OS, Santos QR, et al.Comparação da atividade de ácidos graxos essenciais e biomembranana microbiota de feridas crônicas infectadas. Rev Eletr Enf 2008; 10:890-905.
30. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49:999-1005.
31. Rigatti F, Tizotti MK, Horner R, Domingues VO, Martini R, Letícia EM, et al. Bacteremias por Staphylococcus coagulase negativos oxacilina resistentes em um hospital escola na cidade de Santa Maria, Estado do Rio Grande do Sul. Rev Soc Bras Med Trop 2010; 43:686-690.
32. Sousa-Júnior FC, Néri GS, Silva AK, Araújo BPRC, Guerra MJPD, Fernandes MJBC, et al. Evaluation of different methods for detecting methicillin resistance in Staphylococcus aureus isolates in a university hospital located in the northeast of Brazil. BMJ 2010; 41:316-320.
33. Keim LS, Torres-Filho SR, Patricia VS, Lenise AT. Prevalence, aetiology and antibiotic resistance profiles of coagulase negative Staphylococci isolated in a teaching hospital. Braz J Microbiol 2011; 42:248-255.
34. Baraboutis I G, Tsagalou EP, Papakonstantinou I, Marangos MN, Gogos C, Skoutelis AT, et al. Length of exposure to the hospital environment is more important than antibiotic exposure in healthcare associated infections by methicillin-resistant Staphylococcus aureus: a comparative study. Braz J Infect Dis 2011; 15:426-435.
35. Liu C, Bayer A, Cosgrove, SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical Practice Guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. CID 2011; 52:18-55.
36. Tavares W. Antibióticos e quimioterápicos para o clínico. Editora Atheneu: São Paulo; 2009. p. 599.
37. Lima ALLM, Oliveira PRD. Recomendações para o manejo das infecções em úlceras neuropáticas das extremidades inferiores. Bevilacqua Editora: São Paulo; 2011. p. 14.
38. O'Meara S, Al-Kurdi D, Ologun Y, Ovington LG. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2010; 1:1-35.
39. Robson MC, Cooper DM, Aslam R, Gould LJ, Harding KG, Margolis DJ, et al. Guidelines for the treatment of venous ulcers. Wound Rep Reg 2006; 14:649-662.
40. Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, Handing, KG et al. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Rep Rep 2007; 15:17-22.